A new contest challenges participants to reverse their biological age. Over six months, competitors will undergo a battery of tests, from blood samples to brain scans, in a bid to look younger. Neuroscientist Christin Glorioso, CEO of NeuroAge Therapeutics, hopes to gather valuable data on aging processes and potential longevity interventions.
The competition, open to both standard participants and ‘ultra’ competitors who pay a premium for additional tests, promises a leaderboard that tracks progress. Initial results suggest some impressive reversals, but the true test will be in the long term.
Despite the allure of biological youth, the accuracy and utility of these tests remain uncertain. For now, they offer a fascinating glimpse into the complex science of aging.
Meanwhile, Glorioso envisions broader implications, suggesting that slowing aging could save trillions in healthcare costs. As the race begins in January, the world watches, wondering how much closer we are to eternal youth—or just more nuanced metrics of our mortality.
